Æȷοì
Daniela Pende
Daniela Pende
Ospedale Policlinico San Martino
hsanmartino.itÀÇ À̸ÞÀÏ È®ÀεÊ
Á¦¸ñ
Àοë
Àοë
¿¬µµ
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
A Moretta, C Bottino, M Vitale, D Pende, C Cantoni, MC Mingari, ...
Annual review of immunology 19 (1), 197-223, 2001
21832001
Receptors for HLA class-I molecules in human natural killer cells
A Moretta, C Bottino, M Vitale, D Pende, R Biassoni, MC Mingari, ...
Annual review of immunology 14 (1), 619-648, 1996
10581996
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino, R Castriconi, D Pende, P Rivera, M Nanni, B Carnemolla, ...
The Journal of experimental medicine 198 (4), 557-567, 2003
10502003
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
D Pende, S Parolini, A Pessino, S Sivori, R Augugliaro, L Morelli, ...
The Journal of experimental medicine 190 (10), 1505-1516, 1999
10331999
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.
L Ruggeri, A Mancusi, M Capanni, E Urbani, A Carotti, T Aloisi, M Stern, ...
Blood, The Journal of the American Society of Hematology 110 (1), 433-440, 2007
7602007
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to ¡¦
D Pende, P Rivera, S Marcenaro, CC Chang, R Biassoni, R Conte, ...
Cancer research 62 (21), 6178-6186, 2002
6892002
Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia
RT Costello, S Sivori, E Marcenaro, M Lafage-Pochitaloff, ...
Blood, The Journal of the American Society of Hematology 99 (10), 3661-3667, 2002
5882002
Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.
A Moretta, S Sivori, M Vitale, D Pende, L Morelli, R Augugliaro, C Bottino, ...
The Journal of experimental medicine 182 (3), 875-884, 1995
5471995
NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural ¡¦
S Sivori, D Pende, C Bottino, E Marcenaro, A Pessino, R Biassoni, ...
European journal of immunology 29 (5), 1656-1666, 1999
5381999
Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset ¡¦
A Moretta, C Bottino, D Pende, G Tripodi, G Tambussi, O Viale, A Orengo, ...
The journal of experimental medicine 172 (6), 1589-1598, 1990
4991990
NK-dependent DC maturation is mediated by TNF¥á and IFN¥ã released upon engagement of the NKp30 triggering receptor
M Vitale, MD Chiesa, S Carlomagno, D Pende, M Arico, L Moretta, ...
Blood 106 (2), 566-571, 2005
4832005
HLA-haploidentical stem cell transplantation after removal of ¥á¥â+ T and B cells in children with nonmalignant disorders
A Bertaina, P Merli, S Rutella, D Pagliara, ME Bernardo, R Masetti, ...
Blood, The Journal of the American Society of Hematology 124 (5), 822-826, 2014
4782014
Analysis of the receptor-ligand interactions in the natural killer–mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the ¡¦
D Pende, GM Spaggiari, S Marcenaro, S Martini, P Rivera, A Capobianco, ...
Blood 105 (5), 2066-2073, 2005
4602005
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
D Pende, C Cantoni, P Rivera, M Vitale, R Castriconi, S Marcenaro, ...
European journal of immunology 31 (4), 1076-1086, 2001
4542001
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and ¡¦
D Pende, S Marcenaro, M Falco, S Martini, ME Bernardo, D Montagna, ...
Blood, The Journal of the American Society of Hematology 113 (13), 3119-3129, 2009
4432009
HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells
E Carbone, P Neri, M Mesuraca, MT Fulciniti, T Otsuki, D Pende, V Groh, ...
Blood 105 (1), 251-258, 2005
4152005
The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like ¡¦
D Pende, R Biassoni, C Cantoni, S Verdiani, M Falco, C Di Donato, ...
The Journal of experimental medicine 184 (2), 505-518, 1996
4121996
Human natural killer cell receptors and co‐receptors
R Biassoni, C Cantoni, D Pende, S Sivori, S Parolini, M Vitale, C Bottino, ...
Immunological reviews 181 (1), 203-214, 2001
4082001
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
T Lakshmikanth, S Burke, TH Ali, S Kimpfler, F Ursini, L Ruggeri, ...
The Journal of clinical investigation 119 (5), 1251-1263, 2009
4052009
Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytes
A Moretta, R Biassoni, C Bottino, D Pende, M Vitale, A Poggi, MC Mingari, ...
Immunological reviews 155 (1), 105-117, 1997
3961997
ÇöÀç ½Ã½ºÅÛÀÌ ÀÛµ¿µÇÁö ¾Ê½À´Ï´Ù. ³ªÁß¿¡ ´Ù½Ã ½ÃµµÇØ ÁÖ¼¼¿ä.
ÇмúÀÚ·á 1–20